SCHEDULE: Lantronix Resolves Shareholder Dispute, Appoints New Director and Initiates Strategic Review

Lantronix, Inc. has entered into a cooperation agreement with activist shareholders, including Chain of Lakes Investment Fund, LLC, to resolve a proxy contest by appointing a new director and committing to evaluate strategic alternatives for the company.

Summary

• Lantronix, Inc. (the Company) and a group of activist shareholders, Chain of Lakes Investment Fund, LLC, Haluk L. Bayraktar, and Emre Aciksoz (collectively, the Reporting Persons), have entered into a Cooperation Agreement as of June 24, 2025.
• The agreement resolves a prior dispute where the Reporting Persons, who collectively beneficially own 3,072,343 shares (7.9% of outstanding common stock), had jointly filed a Schedule 13D on June 2, 2025, indicating an intent to run a competing proxy solicitation to replace a majority of the Board of Directors.
• Under the terms, the Company's Board will increase from five to six directors, and James Auker will be appointed as the new director, with the Company agreeing to nominate and support his election at the 2025 Annual Meeting of Stockholders.
• The Company commits to using its reasonable best efforts to engage a nationally recognized investment bank or financial advisor within 60 days of James Auker's appointment to evaluate strategic alternatives, including a potential sale of the company, acquisitions, divestitures, partnerships, joint ventures, or continuing as an independent publicly traded entity.
• The Reporting Persons agree to a standstill, limiting their ability to acquire additional shares, nominate directors, or engage in proxy solicitations, and commit to voting their shares in favor of Board-nominated directors and Board recommendations on most proposals, with exceptions for Extraordinary Transactions and ISS/Glass Lewis recommendations (excluding director elections/removals).
• The Cooperation Agreement includes non-disparagement and no-litigation clauses between the parties.
• The initial term of the agreement ends on the earlier of 15 days prior to the 2026 annual meeting nomination deadline or 120 days prior to the first anniversary of the 2025 Annual Meeting, with a potential extension if the New Director is renominated.

Sentiment

Score: 7

Explanation: The agreement successfully de-escalates a shareholder conflict and commits the company to a formal strategic review process, which could unlock significant value. While a sale is not guaranteed, the structured approach to exploring alternatives is a positive step towards addressing shareholder concerns about value creation.

Positives

• Resolution of a potential proxy contest, avoiding a costly and potentially disruptive shareholder battle.
• Appointment of James Auker, a new independent director, to the Board, potentially bringing fresh perspectives and expertise.
• Commitment by Lantronix to engage a financial advisor within 60 days to evaluate strategic alternatives, including a potential sale, which aligns with the activist shareholders' goal of unlocking shareholder value.
• The standstill agreement provides a period of stability for the Company, reducing immediate activist pressure and allowing the Board to focus on strategic initiatives.
• The agreement outlines a clear path for future engagement and potential value creation through a formal strategic review process.

Negatives

• The agreement does not guarantee a sale of the company or an expedited return of shareholder capital, as the evaluation of strategic alternatives does not obligate the Company to pursue or consummate any transaction.
• The activist shareholders' initial demand to replace a majority of the Board was not fully met, as only one new director is being appointed.
• The standstill provisions limit the Reporting Persons' ability to exert further pressure or acquire additional shares, potentially reducing their leverage in future discussions.

Risks

• The evaluation of strategic alternatives may not result in a transaction that satisfies shareholder expectations or leads to a significant return of capital.
• The new director, James Auker, may not be able to effectively influence the Board's strategic direction to the extent desired by the activist shareholders.
• Future disagreements could arise between the Company and the Reporting Persons if the outcomes of the strategic review do not align with the Reporting Persons' objectives.
• The termination clauses of the agreement, particularly the 1% ownership threshold for replacement director recommendations, could impact the Reporting Persons' long-term influence.

Future Outlook

The Company is committed to evaluating strategic alternatives, including a potential sale, acquisitions, divestitures, partnerships, joint ventures, or continuing as an independent publicly traded entity. This evaluation will be conducted in consultation with a nationally recognized investment bank or financial advisor and will be periodically reviewed and reassessed by the Board.

Management Comments

• Reporting Persons' view: "the Issuer's Board of Directors... had been highly ineffective at creating any sustainable shareholder value since the Issuer's shares began to be publicly traded on August 4, 2000."
• Reporting Persons' view: "the ongoing lack of scale in the Issuer's business, combined with its highly inefficient public-company structure, left shareholders at serious risk of further value degradation."
• Reporting Persons' view: "the Issuer's business presented significantly more value to a strategic acquirer than its public market valuation."

Industry Context

This agreement reflects a common dynamic in the public markets where activist investors, believing a company is undervalued, seek to influence corporate strategy and governance to unlock shareholder value. The focus on evaluating strategic alternatives, particularly a potential sale, is a typical outcome of such engagements, aiming to bridge the gap between public market valuation and perceived intrinsic value, often through a change of control or significant corporate restructuring.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: The agreement aims to enhance shareholder value through a formal strategic review process and resolves a potential proxy contest, reducing uncertainty. The activist group's influence is now channeled through a board seat and a defined process.
• Management and Board: The Board gains a new director and a clear mandate to explore strategic alternatives. Management will be tasked with working with the appointed financial advisor on this review.
• Employees: No direct impact is mentioned, but a potential sale or other strategic transaction resulting from the review could lead to changes in company structure or operations that might affect employees.
• Creditors: No direct impact mentioned, but any significant strategic transaction could alter the company's financial structure or risk profile, which could indirectly affect creditors.

Next Steps

• Lantronix Board to increase its size from five to six directors.
• Lantronix Board to appoint James Auker as the new director.
• Lantronix to nominate James Auker for election at the 2025 Annual Meeting of Stockholders.
• Lantronix to engage a nationally recognized investment bank or financial advisor within 60 days following James Auker's appointment.
• The Board, in consultation with the financial advisor, will periodically review and reassess strategic alternatives.
• Lantronix to issue a mutually agreeable press release announcing the terms of the agreement.
• Lantronix to file a Current Report on Form 8-K with the SEC.
• Chain of Lakes Investment Fund, LLC to file an amended Schedule 13D with the SEC.

Key Dates

Recommendation

Keywords

Lantronix, Cooperation Agreement, Shareholder Activism, Corporate Governance, Strategic Alternatives, Board of Directors, Proxy Contest, Investment Fund, James Auker, Chain of Lakes Investment Fund, SEC Filing, Schedule 13D